Apr 15 |
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
|
Mar 28 |
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
|
Mar 26 |
CHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
|
Mar 5 |
Prothena to Participate in Upcoming Healthcare Conferences
|
Mar 4 |
Prothena Appoints David Ford to Newly Created Chief People Officer Position
|
Feb 23 |
Prothena: Alzheimer's Data Update In 2024 Could Move The Needle
|
Feb 22 |
Prothena files to offer ordinary shares
|
Feb 21 |
Prothena appoints Daniel G. Welch as Chair Designate
|
Feb 21 |
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
|
Feb 17 |
Prothena Full Year 2023 Earnings: Beats Expectations
|